Function-focused single-cell analysis to accelerate antibody discovery

The antibody discovery landscape is at a turning point. As the demand for more effective and targeted therapeutics grows to tackle challenging targets, traditional methods—focused on binding rather than function—are no longer sufficient. This white paper explores how a shift to function-focused screening, enabled by Lightcast’s single-cell analysis platform, can dramatically improve hit quality and streamline workflows. From improving lead selection to overcoming challenges in ADC development, this white paper is essential reading for anyone looking to modernise their discovery pipeline.